MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keaa876

Медицинская библиотека · Rheumatology (Oxford, England) · 2021

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model.

Krabbe Simon, Grøn Kathrine L, Glintborg Bente, Nørgaard Mette, Mehnert Frank, Jarbøl Dorte E, Østergaard Mikkel, Hetland Merete L

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Serious infection is a concern for patients with inflammatory joint diseases treated with biological drugs (bDMARDs). The objectives were to compare risk of serious infection, defined as infection leading to hospitalization, in patients initiating bDMARD treatment with that in the general population and, second, to develop a simple clinical prediction model and to obtain risk estimates for individual patients.

METHODS

This was a matched-cohort study based on nationwide registries in Denmark. Patients with RA, axial SpA and PsA initiating first bDMARD monitored in the DANBIO registry were matched 1:10 by age, gender and postal code with controls from the general population. The risk of serious infection during 12 months' follow-up was assessed with Cox regression. Prediction models were developed using logistic regression and compared using area under the receiver operating characteristic curve (AUC).

RESULTS

We included 11 372 patients and 113 715 controls. During follow-up, 522 patients (4.6%) and 1434 controls (1.3%) developed a serious infection (hazard ratio 3.7, 95% CI 3.4, 4.1). Age-stratified risk was largely similar across diagnoses. A simple prediction model, the 'DANBIO infection risk score', based on age and a count of six clinical risk factors had moderate discriminative power (internal validation: AUC 0.69) that was comparable to that of the existing RABBIT (Rheumatoide Arthritis Beobachtung der BIologika-Therapie) Risk Score (external validation: AUC 0.68).

CONCLUSION

Patients with inflammatory joint diseases initiating bDMARD treatment had a four times increased risk of serious infection compared with the general population. A simple prediction model, feasible for shared decision-making, was developed to obtain risk estimates for individual patients.

Для цитирования: Krabbe Simon, Grøn Kathrine L, Glintborg Bente, Nørgaard Mette, Mehnert Frank, Jarbøl Dorte E, Østergaard Mikkel, Hetland Merete L. Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model.. Rheumatology (Oxford, England). 2021. DOI: 10.1093/rheumatology/keaa876.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.